For each patient with established ASCVD receiving stabilised LLT, we: 1) calculated their absolute LDL-C reduction required to achieve LDL-C levels of 70 mg/dL and 55 mg/dL; 2) predicted their 10-year CV risk using the REACH score based on demographic and medical history; 3) simulated ...
On the other hand ACC/AHA 10-year ASCVD risk index is better in estimating CV risk in RA patients. However, still additional modificiations, like age at disease onset, methotrexate usage, ESR are required to fully identify high-risk RA patients.Disclosure of InterestNone declaredDOI10.1136/ann...
If you are an adult male weighing >60kg, either 300ml of wine or,700ml of beer or, 60ml of whiskey or Rum per day is permissible. The dose is half for men weighing less than 60kgs or woman of any weight. Provided there is no family history of addiction, colon or breast c...
Ten-year cardiovascular risk at two medical checkups conducted an average of 1.5 years apart was calculated using the Framingham Risk Score (FRS) and the Atherosclerotic Cardiovascular Disease Risk Estimator (ASCVD). “Our study showed that the reduction in serum total testosterone levels were ...
- Coronary artery calcium score - Atherosclerotic Cardiovascular Disease (ASCVD) Risk Estimator -- an equation to calculate the 10-year future risk of a heart attack Based on these tests, your doctor will decide if you should be on a statin. (MORE: Vast majority of...
as an element of novelty, a new prediction model tailored for individuals with T2DM, SCORE2-Diabetes [13]. This new algorithm is developed to estimate the 10-year risk of fatal or non-fatal CV events in individuals with T2DM without atherosclerotic cardiovascular disease (ASCVD) or severe targe...
The investigators calculated ten-year CVD risk probabilities at baseline for the 19,114 ASPREE participants using the Framingham score (up to 75 years) and the atherosclerotic cardiovascular disease (ASCVD) pooled cohort risk equations (up to 79 years) and divided them into thirds. Aspirin Should...
© 2023, Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc. on behalf of the International Society of Nephrology under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ASCVDatherosclerotic cardiovascular disease,CKD-MBDchronic kidney disease...